Replies to post #4755 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

RECAF (Cancer vs normals) ** 90% 100%
RECAF (Cancer vs benign) *** 88% 100%

Yes, I have read that older data and hose are great results. Why have the lastest two press releases on prostate cancer not reflected those same great results?